Granulocyte colony-stimulating factor (G-CSF) has been used clinically as an auxiliary chemotherapeutic agent due to its functionality in reducing chemotherapy-induced infections in cases of nonlymphoid malignancies, curing neutropenia and mobilizing hematopoietic cells into peripheral blood through binding to cognate cell surface receptors. Here, CSF3 is linked to Decreased total neutrophil count.